Follow-up Study of Janiger LSD Research

Investigators: Rick Doblin, Jerry Beck, PhD, Kate Chapman, Maureen Alioto Los Angeles Area, California Contact Sponsor: MAPS The following report constitutes a forty-year+ follow-up interview study of …

MDMA and Memory

Investigators: Karen Bolla, PhD et al. Johns Hopkins University – Baltimore, Maryland Sponsor: NIH Neuropsychological memory testing of MDMA users and controls. Also see Alex Gamma – MDMA and …

MDMA Pharmacokinetics

Investigator: Rudolf Brenneisen, PhD University of Bern, Switzerland Contact: br> Completed and published, just a few subjects. Also see the details and references section.

MDMA Neurotoxicity Study

Investigators: Una McCann, MD, George Ricaurte, MD, PhD Johns Hopkins University – Baltimore, Maryland Sponsor:NIH PET scan study, MDMA Neurotoxicity, MDMA Users vs. Control Group. MAPS Commentary …

Human Psychopharmacology of N,N-dimethyltryptamine

Investigator: Rick Strassman, MD University of New Mexico, USA Contact: Sponsor: NIDA Psychobiological study, finished and published. MAPS Bulletin – Volume 6 Number 1 Autumn 1995 University of New …

Psilocybins Effects on Cognition

Investigator: Manfred Spitzer, MD, PhD et al. Psychiatrische Universitats Klinic, Heidelberg, Germany Human clinical study, completed and published. More psilocybin research in Germany Spitzer M, et al. …

Human Psychopharmacology of Psilocybin

Investigator: Rick Strassman, MD University of New Mexico, USA Psychobiological study. Phase 1 dose-response study Sponsor: NIDA Begun, not completed due to personal reasons unrelated to study itself. …

FY 1998 Financial Report

You can read this report in its original form here. MAPS IRS Form 990 for 1998 in PDF format Fiscal Year June 1, 1997 — May 31, 1998 (FY 97-98) was a strong year for MAPS with a combination of important …

The Concord Prison Experiment Experiment Follow-Up

Investigator: Rick Doblin, Ph.D. This study, originally published in the Journal of Psychoactive Drugs [Oct-Dec 1998] is one in a series of long-term follow-ups to early psychedelic research that MAPS …

FY 1997 Financial Report

You can read this report in its original form here. MAPS' income in FY 96-97 was $558,683. FY 96-97 represented a dramatic increase in income, expenditures and number of projects over FY 95- 96. FY …